SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001615219-22-000028
Filing Date
2022-03-25
Accepted
2022-03-25 17:00:43
Documents
57
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K flks-20211231.htm   iXBRL 10-K 1247652
2 EX-23.1 slrx12312021eyconsent10-k2.htm EX-23.1 4741
3 EX-31.1 slrx20211231ex-3112.htm EX-31.1 10796
4 EX-31.2 slrx12312021-312expfocerti.htm EX-31.2 10815
5 EX-32.1 slrx12312021-321ex906peoce.htm EX-32.1 5627
6 EX-32.2 slrx12312021-322ex906pfoce.htm EX-32.2 5493
12 flks-20211231_g1.jpg GRAPHIC 113051
  Complete submission text file 0001615219-22-000028.txt   4795806

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flks-20211231.xsd EX-101.SCH 24589
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT flks-20211231_cal.xml EX-101.CAL 40094
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT flks-20211231_def.xml EX-101.DEF 103990
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flks-20211231_lab.xml EX-101.LAB 419655
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flks-20211231_pre.xml EX-101.PRE 249761
51 EXTRACTED XBRL INSTANCE DOCUMENT flks-20211231_htm.xml XML 514607
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36812 | Film No.: 22772184
SIC: 2834 Pharmaceutical Preparations